| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 6, 3065-3072, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
GJ Kato and CV Dang
Department of Pediatric, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
The c-Myc protein, the product of the c-myc proto-oncogene, is a nuclear phosphoprotein with DNA binding properties. Deregulated c-myc expression participates in the development of experimentally induced tumors, and its expression appears to be abnormal in many naturally occurring malignancies. Although the precise molecular mechanism of c- Myc activity in oncogenesis and in normal cell proliferation is unknown, recent advances have uncovered a series of molecular and cellular properties of c-Myc. These properties include nuclear localization, transcriptional activation, oligomerization nonspecific and specific DNA binding. Recently, the c-Myc protein was found to heterodimerize with Max, a protein that cooperates with c-Myc to bind specifically to a core DNA sequence, CAC(G/A)TG. These characteristics suggest that c-Myc participates in the regulation of gene transcription in normal and neoplastic cells.
This article has been cited by other articles:
|
|
 |
|
  K. Kahnt, K. Matz-Rensing, P. Hofmann, C. Stahl-Hennig, and F.-J. Kaup SIV-associated Lymphomas in Rhesus Monkeys (Macaca mulatta) in Comparison with HIV-associated Lymphomas Vet. Pathol., January 1, 2002; 39(1): 42 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bourgarel-Rey, S. Vallee, O. Rimet, S. Champion, D. Braguer, A. Desobry, C. Briand, and Y. Barra Involvement of Nuclear Factor kappa B in c-Myc Induction by Tubulin Polymerization Inhibitors Mol. Pharmacol., April 16, 2001; 59(5): 1165 - 1170. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. P. Kehrer and S. S. Biswal The Molecular Effects of Acrolein Toxicol. Sci., September 1, 2000; 57(1): 6 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Niklinski, G. Claassen, C. Meyers, M. A. Gregory, C. J. Allegra, F. J. Kaye, S. R. Hann, and M. Zajac-Kaye Disruption of Myc-Tubulin Interaction by Hyperphosphorylation of c-Myc during Mitosis or by Constitutive Hyperphosphorylation of Mutant c-Myc in Burkitt's Lymphoma Mol. Cell. Biol., July 15, 2000; 20(14): 5276 - 5284. [Abstract] [Full Text]
|
|
|
|
|
|
J. Yu, C. Angelin-Duclos, J. Greenwood, J. Liao, and K. Calame Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase Mol. Cell. Biol., April 1, 2000; 20(7): 2592 - 2603. [Abstract] [Full Text]
|
|
|
|
|
|
C. V. Dang c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism Mol. Cell. Biol., January 1, 1999; 19(1): 1 - 11. [Full Text] [PDF]
|
|
|
|
 |
|
 B.-F. Chen, M.-L. Chen, D.-C. Liang, H.-C. Liu, and S.-H. Chen The Relationship of N-myc Amplification and Apoptosis in Neuroblastoma International Journal of Surgical Pathology, January 1, 1999; 7(1): 19 - 25. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Kai, A. Muraishi, Y. Sugiu, H. Nishi, Y. Seki, F. Kuwahara, A. Kimura, H. Kato, and T. Imaizumi Expression of Proto-oncogenes and Gene Mutation of Sarcomeric Proteins in Patients With Hypertrophic Cardiomyopathy Circ. Res., September 21, 1998; 83(6): 594 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. He, A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler Identification of c-MYC as a Target of the APC Pathway Science, September 4, 1998; 281(5382): 1509 - 1512. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Facchini and L. Z. Penn The molecular role of Myc in growth and transformation: recent discoveries lead to new insights FASEB J, June 1, 1998; 12(9): 633 - 651. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. M. English, G. Pearson, R. Baer, and M. H. Cobb Identification of Substrates and Regulators of the Mitogen-activated Protein Kinase ERK5 Using Chimeric Protein Kinases J. Biol. Chem., February 13, 1998; 273(7): 3854 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Boudjelal, R. Taneja, S. Matsubara, P. Bouillet, P. Dolle, and P. Chambon Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells Genes & Dev., August 15, 1997; 11(16): 2052 - 2065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-Y. Chou, G. W. Hart, and C. V. Dang c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas J. Biol. Chem., August 11, 1995; 270(32): 18961 - 18965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Barrett, B. C. Lewis, A. T. Hoang, R. J. Alvarez , Jr., and C. V. Dang Cyclin A Links c-Myc to Adhesion-independent Cell Proliferation J. Biol. Chem., July 7, 1995; 270(27): 15923 - 15925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A J Wagner, J M Kokontis, and N Hay Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes & Dev., December 1, 1994; 8(23): 2817 - 2830. [Abstract] [PDF]
|
|
|
|
|
|
E. Postel, S. Berberich, S. Flint, and C. Ferrone Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis Science, July 23, 1993; 261(5120): 478 - 480. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
